NDC 70518-0552-03 - Glipizide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0552
- Requested NDC
- 70518-0552-03
- Package NDCs from labels
- 70518-0552-0, 70518-0552-1, 70518-0552-2, 70518-0552-3, 70518-0552-4, 70518-0552-5, 70518-0552-03
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only | REMEDYREPACK INC. | 2026-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-0552-0 | Glipizide | 30 in 1 BLISTER PACK | TABLET | 30 | 21 | |
| 70518-0552-1 | Glipizide | 180 in 1 BOTTLE, PLASTIC | TABLET | 180 | 21 | |
| 70518-0552-2 | Glipizide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 21 | |
| 70518-0552-3 | Glipizide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 21 | |
| 70518-0552-4 | Glipizide | 30 in 1 BLISTER PACK | TABLET | 30 | 21 | |
| 70518-0552-5 | Glipizide | 60 in 1 BLISTER PACK | TABLET | 60 | 21 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-0552 | GLIPIZIDE TABLET [REMEDYREPACK INC.] | 18 | Current NDC, Legacy NDC, 6 package rows | 20250426_212897cb-7de7-4711-aaf4-44234f950e9f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glipizide and metformin hcl | GLIPIZIDE AND METFORMIN HCL | Chartwell RX, LLC | ac018f64-fd9d-4b3c-b0ac-ca305b8df635 | 2026-11-05 | Boxed warning, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 726fd41e-7831-4f94-8b28-d139105aad68 | 2026-11-04 | Warnings, Adverse reactions | 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | Bryant Ranch Prepack | a59e2aaf-692c-4696-817b-3fed7a9dc52c | 2026-11-04 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | a38cfe61-4aa5-498c-bca5-03a8213303bb | 2026-10-14 | Warnings, Adverse reactions | ANDA075795 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 16fb8bc7-1db1-477e-a201-b3b678b8a84c | 2026-10-13 | Warnings, Adverse reactions | ANDA075795 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | AiPing Pharmaceutical, Inc. | ccfa5a38-3f90-48f4-b226-51e91497c06f | 2026-10-09 | Warnings, Adverse reactions | 310488 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | AiPing Pharmaceutical, Inc. | 2110a7ca-3c1f-4db4-9211-65546b74533c | 2026-10-09 | Warnings, Adverse reactions | 310488 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 41d4e09b-b90c-4243-acd8-f2e06ebf4089 | 2026-10-09 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | 861609da-6f69-43cf-a6a3-9f45a1d9eb23 | 2026-10-02 | Warnings, Adverse reactions | 310490 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | c38c3c72-0ef2-4c06-8c67-a3f428ad172b | 2026-10-02 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | NuCare Pharmaceuticals, Inc. | 5ce323e4-ea8c-22b5-e063-6294a90a15bf | 2026-10-02 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 04e18105-0bd2-4353-b7d2-a73749de32b8 | 2026-09-29 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | d9b6464f-6fe6-446e-8150-d0c15c46fee8 | 2026-09-28 | Warnings, Adverse reactions | 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | 1b2e5656-9da9-4fab-bf01-ed75896b836a | 2026-09-23 | Warnings, Adverse reactions | ANDA075795 310488 X7WDT95N5C |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | 3f2599c6-9e33-487e-9379-6477bb121461 | 2026-09-22 | Warnings, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | REMEDYREPACK INC. | 212897cb-7de7-4711-aaf4-44234f950e9f | 2026-09-22 | Warnings, Adverse reactions | ANDA075795 70518-0552-4 70518-0552-5 70518-0552-1 70518-0552-3 70518-0552-2 70518-0552-0 70518-0552 70518055203 310490 5c17772f-378d-1fec-e063-6394a90a01fd 212897cb-7de7-4711-aaf4-44234f950e9f X7WDT95N5C |
| Glipizide | GLIPIZIDE | REMEDYREPACK INC. | 376ce3cf-4e1b-4b5f-b3e7-cc9fc4a5aeb4 | 2026-09-22 | Warnings, Adverse reactions | ANDA075795 310488 X7WDT95N5C |
| Glipizide | GLIPIZIDE | Oxford Pharmaceuticals, LLC | 87cd4930-ba68-4acf-bf74-619c477b557d | 2026-09-17 | Warnings, Adverse reactions | 310488 310490 X7WDT95N5C |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| Glipizide | GLIPIZIDE | NuCare Pharmaceuticals,Inc. | 6282c653-9e9c-6810-e053-2991aa0a4a8e | 2026-09-14 | Warnings, Adverse reactions | ANDA075795 310490 X7WDT95N5C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.